Massimo Galli mostly deals with Internal medicine, Immunology, Virology, Acquired immunodeficiency syndrome and Immunopathology. His Internal medicine research includes themes of Gastroenterology, Lipodystrophy and Surgery. His research integrates issues of Hepatitis C, Randomized controlled trial, Viral load, Ledipasvir and Paritaprevir in his study of Gastroenterology.
Massimo Galli works mostly in the field of Immunology, limiting it down to topics relating to Risk factor and, in certain cases, Lipoatrophy. Massimo Galli has researched Virology in several fields, including Protease, Antibody, Genotype and Severe acute respiratory syndrome coronavirus 2. In his study, Coinfection, Population study and Thrombotic microangiopathy is strongly linked to Cohort study, which falls under the umbrella field of Acquired immunodeficiency syndrome.
His primary scientific interests are in Internal medicine, Immunology, Virology, Acquired immunodeficiency syndrome and Virus. The study incorporates disciplines such as Gastroenterology, Viral load and Hepatitis C virus in addition to Internal medicine. Hepatitis C virus is often connected to Hepatitis C in his work.
His study in Viral disease, Immune system, Immunopathology, Antibody and Cryoglobulinemia are all subfields of Immunology. His Immunopathology study frequently draws connections between related disciplines such as Sida. His Virology study which covers Phylogenetic tree that intersects with Phylogenetics.
The scientist’s investigation covers issues in Internal medicine, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Virology and Disease. His Gastroenterology research extends to the thematically linked field of Internal medicine. Massimo Galli has included themes like Obesity and Intensive care in his Coronavirus disease 2019 study.
His research on Severe acute respiratory syndrome coronavirus 2 also deals with topics like
His primary areas of study are Internal medicine, Virology, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2 and Outbreak. His studies deal with areas such as Gastroenterology and Immunology as well as Internal medicine. His studies in Virology integrate themes in fields like Mutation, Epitope, Antibody and Phylogenetics.
Massimo Galli interconnects Radiological weapon, Clinical trial, Living document and Heparin in the investigation of issues within Coronavirus disease 2019. The concepts of his Severe acute respiratory syndrome coronavirus 2 study are interwoven with issues in Demography, Population screening, Seroprevalence and 2019-20 coronavirus outbreak. His Outbreak study combines topics in areas such as Epidemiology, Phylogenetic tree, Molecular epidemiology, Pandemic and Coronavirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
Andrea Giacomelli;Laura Pezzati;Federico Conti;Dario Bernacchia.
Clinical Infectious Diseases (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks.
The New England Journal of Medicine (2020)
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
Luca Carsana;Aurelio Sonzogni;Ahmed Nasr;Roberta Simona Rossi.
Lancet Infectious Diseases (2020)
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC
Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna.
Frontiers in Microbiology (2019)
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Piercarlo Sarzi-Puttini;Valeria Giorgi;Silvia Sirotti;Daniela Marotto.
Clinical and Experimental Rheumatology (2020)
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
Emma C. Thomson;Emma C. Thomson;Laura E. Rosen;James G. Shepherd;Roberto Spreafico.
Cell (2021)
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
S De Vita;L Quartuccio;M Isola;C Mazzaro.
Arthritis & Rheumatism (2012)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici;M. Alejandra Tortorici;Martina Beltramello;Florian A. Lempp;Dora Pinto.
Science (2020)
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
Cristina Gervasoni;Anna Lisa Ridolfo;Giuliana Trifirò;Sara Santambrogio.
AIDS (1999)
Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.
G Monti;M Galli;F Invernizzi;P Pioltelli.
QJM: An International Journal of Medicine (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Milan
University of Milan
Vita-Salute San Raffaele University
University of Milan
University of Modena and Reggio Emilia
University of Milan
Università Campus Bio-Medico
University of Rome Tor Vergata
University of Milan
Catholic University of the Sacred Heart
Washington University in St. Louis
Duke University
Aston University
Southwest Jiaotong University
University of Cambridge
Imperial College London
Conservation International
Wageningen University & Research
École Polytechnique Fédérale de Lausanne
The University of Texas at Austin
University of Göttingen
University of Connecticut
National Institutes of Health
Charité - University Medicine Berlin
Institute of Cancer Research
University of California, San Francisco